PODENTAMIG
UNII ZT35532VPU

Substance Identification & Data

This profile provides standardized clinical and technical data for Podentamig, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ZT35532VPU.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2851863-52-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

ZT35532VPU

CAS Registry Number

2851863-52-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PODENTAMIG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C171631

National Cancer Institute reference terminology for clinical and research data.

INN ID

13070

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

Podentamig

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Podentamig. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

Podentamig

Common Names & Synonyms

Immunoglobulin, trispecific, anti-(human tumor necrosis factor receptor superfamily protein TNFRSF17) (human-Lama glama monoclonal HPN217 single-domain VHH fragment) fusion protein with peptide linker (GGGGSGGGS) fusion protein with immunoglobulin anti-(human albumin) (human-Lama glama monoclonal HPN217 single-domain VHH fragment) fusion protein with peptide linker (GGGGSGGGS) fusion protein with immunoglobulin anti-(human CD3 antigen ε-chain) (human-Mus musculus monoclonal HPN217 single-chain variable region fragment VH-(GGGGS)3-VL) fusion protein with hexahistidine tag

immunoglobulin single chain VH-VH'-scFvhl, anti-[Homo sapiens TNFRSF17 (TNF receptor superfamily member 17, BCMA, TNFRSF13A, CD269)], anti-[Homo sapiens ALB (albumin, human serum albumin, HSA)] and anti-[Homo sapiens CD3E (CD3 epsilon, Leu-4)], trispecific; IG single chain VH-VH'-scFvhl (1-507) [VH anti-TNFRSF17 Vicpac /Homsap (Vicugna pacos IGHV3S53*01 (83.3%) -(IGHD) -IGHJ4*01 (100%)/Homo sapiens IGHV3-23*04 (73.5%) -(IGHD) -IGHJ4*01 (91.7%) L123>Q (114), (CDR-IMGT [8.6.14] (27-33.51-56.95-108)) (1-119) -9-mer-tetraglycyl-seryl-triglycyl-seryl linker (120-128) -VH anti-ALB (Homo sapiens IGHV3-23*04 (88.5%) -(IGHD) -IGHJ1*01 (81.8%) W118>S (333), G119>S (334), CDR-IMGT [8.8.8] (154-161.179-186.225-232)) (129-243) -9-mer-tetraglycyl-seryl-triglycyl-seryl linker (244-252) - scFvhl anti-CD3E (253-507) [VH Musmus/Homsap (Mus musculus IGHV10-1*02 (89.9%) -(IGHD) -IGHJ3*01 (100%)/Homo sapiens IGHV3-73*01 (85.0%) -(IGHD) -IGHJ5*01 (100%), CDR-IMGT [8.10.16] (278-285.303-312.351-366)) (253-377) -15-mer-tris(tetraglycyl-seryl) linker (378-392) -V-LAMBDA (Homo sapiens IGLV7-43*01 (86.2%) -IGLJ3*02 (100%), CDR-IMGT [9.3.9] (418-426.444-446.483-491)) (393-501)] -hexahistidine tag (502-507)], produced in Chinese hamster ovary (CHO) cells, cell line CHO-DG44, lacking the enzyme dihydrofolate reductase (DHFR), non-glycosylated

podentamig [INN]

Technical Codes

HPN-217

External Clinical & Regulatory Resources

Previous UNIIZT350OYT3I

Next UNIIZT389542XK